Form F-1 Scinai Immunotherapeutic
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- US stock futures rise as oil pullback amplifies Fed rate-hike boost
- Oil falls 3% to one-week low as supply disruption fears ease
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- Exclusive-SK Hynix in talks with Intel about deal to make memory chips in US for the first time, sources say
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Bernstein on Crypto: 'Clarity fails - what next?'
Scinai Immunotherapeutics (SCNI) files for 4.8M share offering by selling stockholders
September 22, 2025 10:50 AM EDTScinai Immunotherapeutics (NASDAQ: SCNI) has filed for up to 4,800,000 ADSs offering by selling stockholders. The ADSs represent 19,200,000,000 common shares,
... More